Pricing Log in Create free account

ARAVIVE, INC (ARAV) vs Revelation Biosciences, Inc. (REVB)

ARAVIVE, INC and Revelation Biosciences, Inc. are both Biotechnology companies. ARAVIVE, INC and Revelation Biosciences, Inc. are of similar size ($3.0M and $3.0M). Revelation Biosciences, Inc. has the higher net margin (0.00% vs −569.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Revelation Biosciences, Inc. leads on 8 and ARAVIVE, INC on 5.

Valuation

Metric ARAV REVB Biotechnology median
P/E n/m n/m 8.50
P/S 0.43 n/m 9.71
P/B 1.78 0.18 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.05 0.86 0.64
EV/Sales (0.44) n/m 9.21
Earnings yield (1,500.00%) (2,564.58%) (33.15%)
Free cash flow yield (2,072.58%) (513.59%) (25.50%)

Profitability

Metric ARAV REVB Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (847.42%) 0.00% 0.00%
Net margin (569.65%) 0.00% 0.00%
Free cash flow margin (849.92%) 0.00% 0.00%
Return on equity (475.98%) (276.43%) (56.36%)
Return on assets (144.19%) (214.63%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARAV REVB Biotechnology median
Revenue growth (TTM) (19.11%) — 6.02%
EPS growth (last fiscal year) (7.69%) 97.72% 30.26%
Revenue growth, 5-year CAGR (25.57%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARAV REVB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.98 6.21 4.72
Net debt to EBITDA 0.77 1.18 0.96

Dividend

Metric ARAV REVB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARAV REVB Biotechnology median
Market cap 2.95m 3.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack